These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients]. Dağlar D; Ergani A; Demirbakan H; Ozhak Baysan B; Ongüt G; Koçak H; Oğünç D; Akbaş H; Yıldırım B; Colak D Mikrobiyol Bul; 2014 Jan; 48(1):143-50. PubMed ID: 24506725 [TBL] [Abstract][Full Text] [Related]
3. Prevalence and clinical expression of HCV-genotypes in haemodialysis-patients of two geographically remote countries: Belgium and Saudi-Arabia. Bosmans JL; Nouwen EJ; Behets G; Gorteman K; Huraib SO; Shaheen FA; Maertens G; Verpooten GA; Elseviers MM; de Broe ME Clin Nephrol; 1997 Apr; 47(4):256-62. PubMed ID: 9128793 [TBL] [Abstract][Full Text] [Related]
4. Serum HCV-RNA and liver histologic findings in patients with long-term normal transaminases. Montalto G; Zignego AL; Ruggeri MI; Giannini C; Soresi M; Monti M; Carroccio A; Careccia G; Di Martino D; Giannelli F Dig Dis Sci; 1997 Aug; 42(8):1703-7. PubMed ID: 9286237 [TBL] [Abstract][Full Text] [Related]
5. Liver disease in dialysis patients with antibodies to hepatitis C virus. al-Wakeel J; Malik GH; al-Mohaya S; Mitwalli A; Baroudi F; el Gamal H; Kechrid M Nephrol Dial Transplant; 1996 Nov; 11(11):2265-8. PubMed ID: 8941588 [TBL] [Abstract][Full Text] [Related]
6. A twelve year natural history of hepatitis C virus infection in hemodialyzed patients. Simon N; Couroucé AM; Lemarrec N; Trépo C; Ducamp S Kidney Int; 1994 Aug; 46(2):504-11. PubMed ID: 7967364 [TBL] [Abstract][Full Text] [Related]
7. Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia. Lopes EP; Gouveia EC; Albuquerque AC; Sette LH; Mello LA; Moreira RC; Coelho MR J Clin Virol; 2006 Mar; 35(3):298-302. PubMed ID: 16290052 [TBL] [Abstract][Full Text] [Related]
8. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Guadagnino V; Stroffolini T; Rapicetta M; Costantino A; Kondili LA; Menniti-Ippolito F; Caroleo B; Costa C; Griffo G; Loiacono L; Pisani V; Focà A; Piazza M Hepatology; 1997 Oct; 26(4):1006-11. PubMed ID: 9328327 [TBL] [Abstract][Full Text] [Related]
9. Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis. Fabrizi F; Lunghi G; Finazzi S; Colucci P; Pagano A; Ponticelli C; Locatelli F Am J Kidney Dis; 2001 Nov; 38(5):1009-15. PubMed ID: 11684554 [TBL] [Abstract][Full Text] [Related]
10. The distribution of hepatitis C virus genotypes in Turkish patients. Abacioglu YH; Davidson F; Tuncer S; Yap PL; Ustacelebi S; Yulug N; Simmonds P J Viral Hepat; 1995; 2(6):297-301. PubMed ID: 8732176 [TBL] [Abstract][Full Text] [Related]
11. Impact of hepatitis C virus duration and hepatitis C virus genotypes on renal transplant patients: correlation with clinicopathological features. Rostaing L; Izopet J; Cisterne JM; Arnaud C; Duffaut M; Rumeau JL; Puel J; Durand D Transplantation; 1998 Apr; 65(7):930-6. PubMed ID: 9565097 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus genotypes and reinfection of the graft during long-term follow-up in 35 liver transplant recipients. Caccamo L; Gridelli B; Sampietro M; Melada E; Doglia M; Lunghi G; Corbetta N; Rossi G; Colledan M; Fassati LR; Fiorelli G; Galmarini D Transpl Int; 1996; 9 Suppl 1():S204-9. PubMed ID: 8959828 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus RNA and liver histology in blood donors reactive to a single antigen by second-generation recombinant immunoblot assay. Zanella A; Conte D; Prati D; Mozzi F; Capelli C; Zanuso F; Fraquelli M; Bosoni P; Vianello L; Pappalettera M Hepatology; 1995 Apr; 21(4):913-7. PubMed ID: 7535737 [TBL] [Abstract][Full Text] [Related]
14. Characterization of differential antibody production against hepatitis C virus in different HCV infection status. Rafik M; Bakr S; Soliman D; Mohammed N; Ragab D; ElHady WA; Samir N Virol J; 2016 Jun; 13():116. PubMed ID: 27357382 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus seroconversion and genotype prevalence in patients and staff on chronic hemodialysis. Zamir D; Storch S; Zonder HB; Zamir C; Weiner P J Clin Gastroenterol; 1999 Jan; 28(1):23-8. PubMed ID: 9916660 [TBL] [Abstract][Full Text] [Related]
16. Incidence and risk factors of hepatitis C virus infection in a haemodialysis unit. Forns X; Fernández-Llama P; Pons M; Costa J; Ampurdanés S; López-Labrador FX; Olmedo E; López-Pedret J; Darnell A; Revert L; Sánchez-Tapias JM; Rodés J Nephrol Dial Transplant; 1997 Apr; 12(4):736-40. PubMed ID: 9141004 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus infections in dialysis centers in The Netherlands: a national survey by serological and molecular methods. Schneeberger PM; Keur I; van der Vliet W; van Hoek K; Boswijk H; van Loon AM; van Dijk WC; Kauffmann RH; Quint W; van Doorn LJ J Clin Microbiol; 1998 Jun; 36(6):1711-5. PubMed ID: 9620405 [TBL] [Abstract][Full Text] [Related]
18. Jaundice at onset signifies a good prognosis in anti-D-associated HCV infection. Sachithanandan S; Fielding JF Eur J Gastroenterol Hepatol; 1997 Jan; 9(1):77-9. PubMed ID: 9031904 [TBL] [Abstract][Full Text] [Related]
19. [Hepatitis C virus genotypes in a province of western Black-Sea region, Turkey]. Aktaş E; Ogedey ED; Külah C; Beğendik Cömert F Mikrobiyol Bul; 2010 Oct; 44(4):647-50. PubMed ID: 21063977 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of antibodies to hepatitis C virus in transfused children with cancer. Monteleone PM; Andrzejewski C; Kelleher JF Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):309-13. PubMed ID: 7978047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]